News

Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will ...
The average of price targets set by Wall Street analysts indicates a potential upside of 145.8% in Pharming Group (PHAR). While the effectiveness of this highly sought-after metric is questionable, ...
Detailed price information for Pharming Group NV (PHGUF) from The Globe and Mail including charting and trades.
Acute Ischemic Stroke companies working in the treatment market are Acticor Biotech, Athersys/Healios K.K., Bristol-Myers Squibb, Lumosa Therapeutics, Abbvie, and others, are developing therapies for ...
Phishing scams costing crypto users millions. Learn how to stay secure while enjoying the financial freedom that digital assets promise.